Abivax SA (AAVXF)
139.00
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Abivax Total Liabilities (Quarterly) : 135.44M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 135.44M |
| December 31, 2025 | 151.66M |
| September 30, 2025 | 165.46M |
| Date | Value |
|---|---|
| June 30, 2025 | 197.11M |
| March 31, 2025 | 187.45M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Poxel SA | -- |
| OSE Immunotherapeutics SA | -- |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 630.42M |
| Shareholders Equity (Quarterly) | 494.98M |
| Debt to Equity Ratio | 0.0796 |
| Current Ratio | 8.247 |
| Net Debt Paydown Yield | 0.09% |